This systematic literature review (SLR) regarding the efficacy, duration of use and safety of
glucocorticoids (GCs), was performed to inform the 2022 update of the EULAR …

Glucocorticoids are effective immunomodulatory drugs used for many inflammatory
disorders as well as in transplant recipients. However, both iatrogenic and endogenous …

Ethnopharmacology relevance Isobavachalcone (IBC) is a natural chalcone compound
widely distributed in traditional Chinese medicine Psoralea corylifolia L., and Tibetan …

Objective To unravel the dynamical trajectory and features of glucocorticoids (GC) tapering
and discontinuation in patients with rheumatoid arthritis (RA) commencing GC with …

Objectives Clinical trials have shown that low-dose glucocorticoid therapy in patients with
RA reduces bone loss in hands or hip, but the effect on osteoporotic fractures is not yet clear …

Objective To assess the effect of proton pump inhibitor (PPI) use on bone mineral density
(BMD) and bone microarchitecture as measured by the trabecular bone score (TBS) in …

Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease characterized by
synovial inflammation and joint bone and cartilage destruction. Curcumin can improve joint …

Objectives Clinical trials have shown a beneficial effect from biological disease-modifying
antirheumatic drugs (bDMARDs) on hand or axial bone loss in patients with rheumatoid …

Introduction Glucocorticoids (GC) are currently recommended as a bridging therapy in
combination with conventional synthetic disease-modifying anti-rheumatic drugs …

Background: Preclinical data suggest that tofacitinib would protect bone health in patients
with rheumatoid arthritis (RA). Objective: To assess fracture risk in tofacitinib RA clinical …